Epilepsy is a chronic neurological disorder characterised by recurrent seizures, significantly impacting a patient's quality of life.1
Effective management often requires long-term medication adherence to prevent breakthrough seizures.1 Levetiracetam, a widely used anticonvulsant, has recently become available in an extended-release (XR) formulation in SA, offering a once-daily dosing option that can improve patient compliance and outcomes.2
IMPORTANCE OF MEDICATION ADHERENCE
Epilepsy affects millions worldwide, and its management typically involves antiepileptic drugs (AEDs) to control seizures. Consistent medication adherence is crucial...